Leading the way
AI gives new life
Spring is the prelude, and all things are harmonious. The 2024 National Breast Cancer Conference and CSCO BC Annual Meeting of the Chinese Society of Clinical Oncology for Breast Cancer (CSCO BC), an annual event in the field of breast cancer, was held in Beijing from April 12th to 13th!
On this occasion, the "Pilot Plan - Follow the 'National Team' to Learn HR+ Standardized Diagnosis and Treatment of Breast Cancer" project initiated by China Medical Tribune and supported by Pfizer was officially launched! Ms. Wang Guoping, Assistant President of China Medical Tribune, Ms. Wang Yu, Vice President of Pfizer China and General Manager of Pfizer Oncology, Mr. Wang Chi, Head of Pfizer China Breast and Urologic Oncology Division, Professor Sun Gang of the Affiliated Cancer Hospital of Xinjiang Medical University, Professor Li Man from the Second Affiliated Hospital of Dalian Medical University participated in the launching ceremony of the project and started a new journey of standardized diagnosis and treatment of breast cancer!
unity is strength
Hand in hand with the "national team" to create a peak of medicine
In 2024, in order to further promote the high-quality development of oncology, under the guidance of the relevant departments and bureaus of the National Health Commission, relying on the "Pilot Plan" project, China Medical Tribune will launch the "Pilot Plan - Follow the 'National Team' to Learn Standardized Diagnosis and Treatment of Breast Cancer" project to help improve the level of standardized diagnosis and treatment in the field of breast cancer.
In order to promote the development of HR+ breast cancer in the direction of standardization, homogeneity and standardization, the sub-project "Pilot Plan - Follow the 'National Team' to Learn HR+ Standardized Diagnosis and Treatment of Breast Cancer" was the first to be carried out in the country, building a medical peak with professional strength and opening a new milestone in the standardized diagnosis and treatment of HR+ breast cancer.
Ms. Wang Guoping, assistant to the president of China Medical Tribune, said in her speech that in the future, China Medical Tribune will continue to join hands with well-known experts in the field of breast in China to gather the wisdom of experts from the "national team", pass on experience, set benchmarks, and promote standardized diagnosis and treatment methods and concepts of breast diseases in multiple dimensions, so as to contribute to the cause of breast cancer prevention and treatment in mainland China.
A blend of wisdom
Work together to improve the ability of standardized diagnosis and treatment of breast cancer
Every footprint shoulders the responsibility and mission of bringing health to thousands of families.
Since entering China 35 years ago, Pfizer has always been committed to the construction and improvement of the breast cancer quality control system, and now it is fully supporting the "Pilot Plan - Follow the 'National Team' to Learn HR+ Breast Cancer Standardized Diagnosis and Treatment" project, and join hands with China Medical Tribune to jointly establish the "HR+ Breast Cancer Standardized Diagnosis and Treatment National Team", by sorting out and summarizing the ideas of HR+ breast cancer standardized diagnosis and treatment, creating the most academically valuable HR+ breast cancer professional content, and effectively improving HR+The clinical diagnosis and treatment capabilities of breast cancer can improve the survival benefits of patients and help more HR+ breast cancer patients achieve high-quality and long-term survival.
Ms. Wang Yu, Vice President of Pfizer China and General Manager of Pfizer Oncology, said in her speech that in the future, Pfizer will continue to actively respond to the call of the country, adhere to the concept of "winning with science and overcoming cancer together", adhere to the commitment of "rooted in China, serve China", empower the construction of the medical and health system with science, work together with all sectors of society, strengthen the influence of science, and help achieve the goal of increasing the five-year survival rate of overall cancer patients by 15% in the "Healthy China 2030" plan as soon as possible!
Leading the way
AI gives new life
In this spring, root down and grow up. We believe that the "Pilot Plan - Follow the 'National Team' to Learn HR+ Standardized Diagnosis and Treatment of Breast Cancer" project will become a powerful engine to promote the improvement of standardized diagnosis and treatment capabilities in the field of breast cancer in China! On April 15th, the first issue of the content will be officially launched on the Yisheng app, and China Medical Tribune invites you to go on an academic journey together!
END